PeptideDB

Letaplimab

CAS No.: 2283356-07-8

Letaplimab (IBI-188), a humanized IgG4 monoclonal antibody targeting CD47—which is often overexpressed in cancer cells
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Letaplimab (IBI-188), a humanized IgG4 monoclonal antibody targeting CD47—which is often overexpressed in cancer cells and acts as a ligand for SIRPα—has been shown to promote phagocytosis of tumor cells [1].
Synonyms IBI-188
molecular weight N/A
CAS 2283356-07-8
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 years